In combination with adeno-associated virus (AAV)-mediated gene delivery, one could envision that ADAMTS5 activity could be significantly reduced in knee joints affected by arthritis and halt disease progression (Evans et al., 2018; Fitzgerald, 2020). This evidence concerns the gene ADAMTS5 and arthritic joint disease.